Wed, April 11, 2018
Tue, April 10, 2018
Mon, April 9, 2018
Fri, April 6, 2018
Thu, April 5, 2018
Wed, April 4, 2018
Tue, April 3, 2018
Mon, April 2, 2018
Thu, March 29, 2018
Wed, March 28, 2018
Tue, March 27, 2018
Mon, March 26, 2018
Fri, March 23, 2018
Thu, March 22, 2018
Wed, March 21, 2018
Tue, March 20, 2018
Mon, March 19, 2018

Arlinda Lee Maintained (AKTX) at Strong Buy with Decreased Target to $160 on, Mar 29th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-160-on-mar-29th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Arlinda Lee of Canaccord Genuity, Maintained "Akari Therapeutics, Plc" (AKTX) at Strong Buy with Decreased Target from $300 to $160 on, Mar 29th, 2018.

Arlinda has made no other calls on AKTX in the last 4 months.



There is 1 other peer that has a rating on AKTX. Out of the 1 peers that are also analyzing AKTX, all agrees with Arlinda's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Madhu Kumar of "B. Riley Securities" Initiated at Hold and Held Target at $60 on, Thursday, February 8th, 2018